Daré will host a conference call and live webcast today, May 13, 2025, at 4:30 p.m. Eastern Time to review financial results ...

Creates commercial opportunity in the estimated up to $4.5 billion compounded hormone therapy market, enabling women to access an evidence-based solutionFour on-market products will accelerate revenue ...

Also, a split-face study showed that daily clindamycin gel resolved 80.9% of lesions (Richey & Hopson, 2006). Topical therapy, however, may be somewhat slower than oral antibiotics in resolving ...

Benzoyl peroxide has antibacterial activity. Topical antibiotics available for treating acne include clindamycin (1% gel, lotion, solution, or pledgets applied b.i.d.), erythromycin (2% gel ...

What it does: Tranexamic acid is becoming increasingly popular in the skincare world for its application in tackling hyperpigmentation and melasma, plus the niacinamide (at a potent 10% concentration) ...

The first FDA-approved product to emerge from Daré’s portfolio of women’s health product candidates is XACIATO™ (clindamycin phosphate) vaginal gel 2%, a lincosamide antibacterial indicated ...

The gel is called Zindaclin, a combination of zinc and the antibiotic clindamycin. In trials of 260 young people with mild to moderate acne, it has been found to be at least as effective as ...

Clindamycin (as phosphate) 1%, benzoyl peroxide 5%; gel. The clindamycin and benzoyl peroxide components individually have been shown to have in vitro activity against Propionibacterium acnes ...